TeneoFour Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Single and Multiple Dosing Study Targeting Biparatopic Antibody CD38 in Healthy Volunteers (NCT05215912) | TeneoFour Inc. | 2022-04-21 |
Track TeneoFour Inc. automatically
Every clearance here is in the API, with alerts when new ones post.